Fidaxomicin Metabolite OP-1118 -D5
Fidaxomicin and its metabolite Fidaxomicin Metabolite OP-1118 are macrocyclic RNA polymerase-inhibiting antibiotics for the treatment of Clostridium difficile infections.
OP-1118-D5 serves as a standard for HPLC-MS
In stock
Catalogue
SC-1155
€3,600.00
| Catalogue | SC-1155 |
|---|---|
| Formula | C48H63D5Cl2O17 |
| CAS | NA |
| MW | 992.99 |
| Appearance | Off-white powder |
| Purity | > 97 % (HPLC-UV λ= 254 nm) |
| Solubility | soluble in Acetonitrile, Methanol, Water/Acetonitrile 50/50 |
| Size | 1 mg / 10 mg |
| Storage | Keep cool and dry. Protect from light and moisture. |
Fidaxomicine and its metabolite Fidaxomicin Metabolite OP-1118 are macrocyclic RNA polymerase-inhibiting antibiotics Publication: 1.Goldstein, E.J. et al.; Clin Infect Dis. 2012 Aug; 55 (Suppl 2), S162-9 2.Babakhani, F. et al.; J. Med. Microbiol 2011, 60, 1213-7 3.Whitman, C.B. et al.; Ann Pharmacother 2012, 46(2) 219-28 4.Poxton, I. R.; Future Microbiol. 2010, 5 (4), 239 (CAS: 1030825-28-5)
OP-1118-D5 serves as a standard for HPLC-MS